Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
23 Results for "
CDK11
" in MedChemExpress (MCE) Product Catalog:
Products (23)
23 Results for "CDK11" in MCE Product Catalog:
14
14 Cited Publications
OTS964 hydrochloride is an orally active, high affinity and selective TOPK (T-lymphokine-activated killer cell-originated protein kinase) inhibitor with an IC50 of 28 nM . OTS964 hydrochloride is also a potent inhibitor of the cyclin-dependent kinase CDK11, which binds to CDK11B with a Kd of 40 nM .
ZNL-05-044 is a CDK11 inhibitor with an IC50s of 0.23 μM and 0.27 μM against CDK11A and CDK11B, respectively (NanoBRET assay). ZNL-05-044 leads to G2/M cell cycle arrest and impairs RNA splicing .
Target:
PROTACs Bcr-Abl CDK Salt-inducible Kinase (SIK) Cyclin G-associated Kinase (GAK) MAP4K MAPKAPK2 (MK2) Ferroptosis ULK LIM Kinase (LIMK)
Research Areas:
DB1113 is a multi-kinase PROTAC degrader. DB1113 induces the ubiquitination and degradation of ABL1, ABL2, BLK, CDK11B, CDK4, CSK, EPHA3, FER, GAK, LIMK1, MAP3K20, MAP4K1, MAP4K2, MAP4K3, MAP4K5, MAPK14, MAPK7, MAPK8, MAPK9, MAPKAPK2, MAPKAPK3, NLK, PDIK1L, PTK2B, RIPK1, RPS6KA1, RPS6KA3, SIK2, SIK3, STK35, TNK2, and ULK1. DB1113 can be used to study diseases or disorders mediated by aberrant kinase activity .
Cat. No.: HY-19718
CAS No.: 1338542-14-5
OTS964 is an orally active, high affinity and selective TOPK inhibitor with an IC50 of 28 nM . OTS964 is also a potent inhibitor of the cyclin-dependent kinase CDK11, which binds to CDK11B with a Kd of 40 nM .
Target:
PROTACs AAK1 Aurora Kinase CaMK CDK Ferroptosis Salt-inducible Kinase (SIK) LIM Kinase (LIMK) ULK NEKs
Research Areas:
DB0614 is a PROTAC based on Cereblon ligand, which is a selective and potent targeted protein degrader of NEK9 inhibitor. DB0614 can degrade ABL1, ABL2, BLK, CDK11B, CDK4, CSK, EPHA3, FER, GAK, LIMK1, MAP3K20, MAP4K1, MAP4K2, MAP4K3, MAP4K5, MAPK14, MAPK7, MAPK8, MAPK9, MAPKAPK2, MAPKAPK3, NLK, PDIK1L, PTK2B, RIPK1, RPS6KA1, RPS6KA3, SIK2, SIK3, STK35, TNK2 and ULK1. DB0614 can be used for research of disease or disorder mediated by aberrant kinase activity .
Cat. No.: HY-RS02372
Target:
Research Areas:
Cdk19 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cdk19 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS02371
Target:
Research Areas:
CDK19 Human Pre-designed siRNA Set A contains three designed siRNAs for CDK19 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-175013
CAS No.: 3068529-24-5
Target:
Research Areas:
CDK6/9-IN-2 is a highly active dual inhibitor of CDK6 (IC50 = 15 nM) and CDK9 (IC50 = 22 nM). CDK6/9-IN-2 is selective for CDK2, CDK8, and CDK11. CDK6/9-IN-2 inhibits the proliferation of HaCaT cells induced by IFN-γ/TNF-α and suppresses the STAT3 pathway and the expression of inflammatory factors. CDK6/9-IN-2 can alleviate psoriatic dermatitis and is useful in psoriasis research .
Cat. No.: HY-182764
CDK11-IN-1 is an orally active cyclin-dependent kinase 11 (CDK11) inhibitor with an IC50 of 4 nM, and it exhibits high selectivity against other kinases including CDK7 and CDK9. CDK11-IN-1 inhibits tumor growth in lung cancer xenograft models. CDK11-IN-1 can be used for lung cancer research .
Cat. No.: HY-182764A
CDK11-IN-1 hydrochloride is an orally active cyclin-dependent kinase 11 (CDK11) inhibitor with an IC50 of 4 nM, and it exhibits high selectivity against other kinases including CDK7 and CDK9. CDK11-IN-1 hydrochloride inhibits tumor growth in lung cancer xenograft models. CDK11-IN-1 hydrochloride can be used for lung cancer research .
Cat. No.: HY-RS02355
Target:
Research Areas:
Cdk11b Rat Pre-designed siRNA Set A contains three designed siRNAs for Cdk11b gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS02354
Target:
Research Areas:
Cdk11b Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cdk11b gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS02353
Target:
Research Areas:
CDK11B Human Pre-designed siRNA Set A contains three designed siRNAs for CDK11B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS02352
Target:
Research Areas:
CDK11A Human Pre-designed siRNA Set A contains three designed siRNAs for CDK11A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Components
CDK11A siRNA-1: 5 nmol (HPLC)
CDK11A siRNA-2: 5 nmol (HPLC)
CDK11A siRNA-3: 5 nmol (HPLC)
siRNA Negative Control: 5 nmol (HPLC)
FAM-labeled siRNA Negative Control: 5 nmol (HPLC)
GAPDH siRNA Positive Control: 5 nmol (HPLC)
Cat. No.: HY-P703552
Purity: ≥ 80%, as determined by reducing SDS-PAGE.
Synonyms: CDK11B; P58 CLK-1; Prev. CDC2L1; CDK11; Galactosyltransferase-Associated Protein Kinase P58/GTA; CLK-1; CDK11-P110; Cell Division Cycle 2-Like Protein Kinase 1; CDK11-P58; CDC-Related Protein Kinase P58; CDK11-P46; Cyclin-Dependent Kinase; Cell Division C
Species:
Human
Source:
Sf9 insect cells
Cat. No.: HY-RS02373
Target:
Research Areas:
Cdk19 Rat Pre-designed siRNA Set A contains three designed siRNAs for Cdk19 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-P706028
Purity: ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: CDK11B; P58 CLK-1; Prev. CDC2L1; CDK11; Galactosyltransferase-Associated Protein Kinase P58/GTA; CLK-1; CDK11-P110; Cell Division Cycle 2-Like Protein Kinase 1; CDK11-P58; CDC-Related Protein Kinase P58; CDK11-P46; Cyclin-Dependent Kinase; Cell Division C
Species:
Human
Source:
Sf9 insect cells
Cat. No.: HY-P706029
Purity: ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: CDK11B; P58 CLK-1; Prev. CDC2L1; CDK11; Galactosyltransferase-Associated Protein Kinase P58/GTA; CLK-1; CDK11-P110; Cell Division Cycle 2-Like Protein Kinase 1; CDK11-P58; CDC-Related Protein Kinase P58; CDK11-P46; Cyclin-Dependent Kinase; Cell Division C
Species:
Human
Source:
Sf9 insect cells
Cat. No.: HY-P702907
Purity: ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: CDK19; Cell Division Protein Kinase 19; Prev. CDC2L6; Cyclin-Dependent Kinase 19; Prev. CDK11; Cyclin-Dependent Kinase 11; BA346C16.3; Death-Preventing Kinase; KIAA1028; CDK8-Like Cyclin-Dependent Kinase; Cell Division Cycle 2-Like Protein Kinase 6; Cycli
Species:
Human
Source:
Sf9 insect cells
Cat. No.: HY-P702699
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: CDK19; Cell Division Protein Kinase 19; Prev. CDC2L6; Cyclin-Dependent Kinase 19; Prev. CDK11; Cyclin-Dependent Kinase 11; BA346C16.3; Death-Preventing Kinase; KIAA1028; CDK8-Like Cyclin-Dependent Kinase; Cell Division Cycle 2-Like Protein Kinase 6; Cycli
Species:
Human
Source:
Sf9 insect cells
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
